ICD Co., Ltd. (KOSDAQ:040910)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,410.00
-50.00 (-1.12%)
Sep 4, 2026, 3:30 PM KST

ICD Co., Ltd. Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
145,311197,041147,61662,274150,945115,769
Other Revenue
-0-00--
145,311197,041147,61662,274150,945115,769
Revenue Growth
-26.39%33.48%137.04%-58.74%30.38%-62.53%
Cost of Revenue
117,910164,064150,86069,915135,06292,238
Gross Profit
27,40232,978-3,244-7,64115,88323,532
Selling, General & Admin
22,06723,77719,94419,32618,01717,350
Research & Development
6,2986,2981,4351,1051,2701,256
Amortization of Goodwill & Intangibles
170.1170.1257.01433.24429.94395.29
Other Operating Expenses
308.33308.33378.29691.79281.79287.82
Operating Expenses
27,59829,30823,63531,61321,01021,821
Operating Income
-196.893,670-26,880-39,254-5,1271,711
Interest Expense
-1,626-1,626-2,349-1,402-1,293-242.45
Interest & Investment Income
333.15333.15442.91563.56511.2365.12
Earnings From Equity Investments
53.0353.03-304.77-1,739--504.62
Currency Exchange Gain (Loss)
-1,197-1,1975,1351,6484,9083,876
Other Non Operating Income (Expenses)
11,366-590.916,127-5,301693.72-1,079
EBT Excluding Unusual Items
8,733643.1-17,829-45,485-306.854,126
Gain (Loss) on Sale of Investments
-265.14-212.11-210.11-228.89-253.89-114.82
Gain (Loss) on Sale of Assets
334.55334.5511.13199.69-5.53100
Asset Writedown
---4,314-833.11-4,776-3,684
Other Unusual Items
-2,741-2,741952.01633.09--
Pretax Income
6,062-1,975-21,390-45,714-5,342427.19
Income Tax Expense
220.667.586,912-4,39676.86-334.62
Earnings From Continuing Operations
5,841-1,983-28,302-41,318-5,419761.81
Minority Interest in Earnings
129.7479.5411.64---
Net Income
5,971-1,903-28,291-41,318-5,419761.81
Net Income to Common
5,971-1,903-28,291-41,318-5,419761.81
Net Income Growth
------97.72%
Shares Outstanding (Basic)
161616161617
Shares Outstanding (Diluted)
161616161617
Shares Change
-2.05%0.31%1.13%0.72%-4.67%-1.58%
EPS (Basic)
364.12-116.56-1738.00-2566.94-339.1145.44
EPS (Diluted)
364.12-116.56-1738.00-2567.00-339.1145.00
EPS Growth
------97.72%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-18,9037,315-30,789-7,560-22,86217,258
Free Cash Flow Per Share
-1152.72447.98-1891.51-469.66-1430.561029.41
Gross Margin
18.86%16.74%-2.20%-12.27%10.52%20.33%
Operating Margin
-0.14%1.86%-18.21%-63.03%-3.40%1.48%
Profit Margin
4.11%-0.97%-19.16%-66.35%-3.59%0.66%
Free Cash Flow Margin
-13.01%3.71%-20.86%-12.14%-15.15%14.91%
EBITDA
3,3438,175-20,445-32,3721,4388,731
EBITDA Margin
2.30%4.15%-13.85%-51.98%0.95%7.54%
D&A For EBITDA
3,5404,5056,4356,8826,5657,020
EBIT
-196.893,670-26,880-39,254-5,1271,711
EBIT Margin
-0.14%1.86%-18.21%-63.03%-3.40%1.48%
Effective Tax Rate
3.64%-----
Advertising Expenses
---2-3